Industrial conglomerate Crane (NYSE: CR) reported Q3 2026 results topping the market’s revenue expectations, with sales up 28.1% year on year to $754.6 million. Its non-GAAP profit of $2.05 per share was 12.8% above analysts’ consensus estimates.
Is now the time to buy CR? Find out in our full research report (it’s free for active Edge members).
Crane (CR) Q3 2026 highlights:
- Revenue $754.6 million vs S&P analysts’ estimates of $736.4 million (28.1% year-on-year growth, 2.5% beat)
- Adjusted EPS $2.05 vs S&P analysts’ estimates of $1.82 (12.8% beat)
- Adjusted EBITDA $180.8 million vs analyst estimates of $170.4 million (24% margin, 6.1% beat)
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $7.31 at the midpoint, a 5.1% increase
- Operating margin 18.6%, down from 20.1% in the same quarter last year
- Organic revenue rose 7.7% year on year (beat)
- Market capitalization $11.47 billion
StockStory’s take
Crane’s third quarter delivered results that outpaced Wall Street’s expectations, prompting a positive market reaction. Management attributed the strong revenue and earnings to broad-based demand across its end markets, particularly in Aerospace and Advanced Technologies, as well as robust order activity in Process Flow Technologies. CEO Alejandro Alcala highlighted the contribution of recent acquisitions, stating, “Demand remains very strong across Aerospace and Advanced Technologies. Momentum continues to build within Process Flow Technologies, and our recent acquisitions are performing well ahead of expectations.” Management also noted that operational execution and portfolio transformation drove performance, with record margins and backlog achieved despite some margin dilution from acquisitions.
Looking ahead, Crane’s updated guidance reflects management’s confidence in continued growth driven by both organic and acquisition-fueled expansion. Leadership expects backlog strength and demand in core markets like aerospace, defense, water, and pharmaceuticals to support higher earnings. Alcala emphasized, “We will enter 2027 with record backlog, strong momentum across both segments, and increasing earnings power.” However, management acknowledged that integration of acquisitions and the ongoing portfolio transformation could impact operating margins, and that certain end markets—such as chemical processing—remain flat, presenting potential upside if recovery materializes.
Key insights from management’s remarks
Crane’s quarterly outperformance was fueled by a combination of end-market strength, successful integration of acquisitions, and shifting portfolio focus toward higher-growth sectors.
- Aerospace and defense tailwinds: Management cited robust demand in commercial aerospace, missile defense, radar, and space-related applications. Alcala highlighted, “We are in about 15 missile programs… and we expect next year to grow 40% to 50%.”
- Process Flow Technologies (PFT) transformation: The segment returned to core growth, with notable wins in cryogenics, power, wastewater, and pharmaceuticals. Management credited a portfolio realignment away from non-residential construction and toward sectors with higher margins and growth prospects.
- Acquisitions exceed plans: Recent deals, such as the additions of Panametrics, Reuter-Stokes, and optek-Danulat, contributed 21% sales growth in the quarter and outperformed initial expectations. Management now expects these acquisitions to hit return-on-invested-capital targets 18 months earlier than planned.
- Portfolio reshaping: The announced acquisition of Trillium Pumps and divestiture of the Building Services and Utilities business completed Crane’s exit from non-residential construction, sharpening its focus on core growth markets.
- Margin dynamics and leverage: While operating margin declined year over year due to dilutive effects from acquisitions, management emphasized that core margin expansion and operating leverage in both Aerospace and Advanced Technologies and PFT remain strong, reflecting pricing, productivity, and favorable business mix.
Drivers of future performance
Management’s outlook centers on sustained demand in core markets, effective execution on acquisitions, and continued margin discipline despite ongoing portfolio changes.
- Backlog and end-market momentum: Strong backlog across aerospace, space, pharmaceuticals, and water/wastewater provides visibility into future sales, with management forecasting above-trend core growth in these segments for the remainder of the year and into 2027.
- Integration and portfolio actions: Leadership is focused on integrating recent acquisitions while managing the timing and effects of the Trillium Pumps acquisition and the Building Services and Utilities divestiture. Management noted that while short-term margin dilution is possible, they expect operating leverage to improve as acquired businesses are integrated into Crane’s operating system.
- Exposure to cyclical recovery: The company’s reduced reliance on chemical processing end markets lowers risk, but management noted that any recovery in this sector—particularly in the U.S. and Middle East—would be additive to guidance, providing further upside potential.
Catalysts in upcoming quarters
Looking ahead, the StockStory team will be tracking (1) the pace of integration and earnings contribution from recent and pending acquisitions like Trillium Pumps, (2) the sustainability of margin expansion in both core and acquired businesses as portfolio reshaping continues, and (3) order activity and backlog growth across key sectors such as aerospace, pharmaceuticals, and water. Any signs of chemical market recovery or progress in further portfolio optimization would also be important milestones.
Crane currently trades at $196.44, up from $192.72 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
High quality stocks for all market conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
